Edition:
United States

Halyard Health Inc (HYH.N)

HYH.N on New York Stock Exchange

47.03USD
12 Dec 2017
Change (% chg)

$0.14 (+0.30%)
Prev Close
$46.89
Open
$47.16
Day's High
$47.19
Day's Low
$46.65
Volume
45,560
Avg. Vol
100,173
52-wk High
$50.93
52-wk Low
$35.25

Chart for

About

Halyard Health, Inc. is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare... (more)

Overall

Beta: --
Market Cap(Mil.): $2,202.72
Shares Outstanding(Mil.): 46.84
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 57.15 15.71
EPS (TTM): -- -- --
ROI: -- 13.34 31.93
ROE: -- 19.96 16.16

BRIEF-Halyard Health to sell S&IP business to Owens & Minor

* Halyard Health, Inc. announces sale of S&IP business to Owens & Minor, Inc. for $710 million

Nov 01 2017

BRIEF-Halyard Health Q3 adjusted earnings of $0.60/shr

* Halyard Health, Inc. announces third quarter 2017 results, raises full-year adjusted diluted eps outlook

Nov 01 2017

BRIEF-Owens & Minor to buy Halyard Health's surgical & infection prevention business for $710 mln

* Owens & Minor to acquire Halyard Health Inc's surgical & infection prevention (S&IP) business for $710 million in cash

Nov 01 2017

BRIEF-Halyard Health reports Q2 EPS of $0.36

* Halyard Health, Inc. Announces second quarter 2017 results, raises full-year adjusted diluted eps outlook

Aug 02 2017

BRIEF-Halyard Health says CEO Robert Abernathy to retire

* Halyard Health Inc - on June 23, co announced , effective June 26, Abernathy will retire as CEO but will continue as chairman of board of directors

Jun 23 2017

Earnings vs. Estimates